Last edition
News about "Series A funding "
Breakthru Medicine Raises USD 60 Million Series A to Advance Cancer Drugs
Founded by biotech veterans Steve Potts, Mark Mulvihill and Brian Barnett, Breakthru Medicine has raised USD 60 million in Series A funding to advance its stealth oncology pipeline, including molecular glues, small molecules and novel ADC payloads.
Series A Funding | 02/02/2026 | By News Bureau
Risa Labs Raises USD 11.1M Series A to Scale AI OS for Oncology Care
The funding led by Cencora Ventures and Optum Ventures will accelerate nationwide deployment of Risa’s AI-driven platform to streamline oncology workflows, reduce delays and improve patient access to cancer therapies.
Series A Funding | 14/01/2026 | By News Bureau | 187
OTR Therapeutics Raises USD 100 Million to Advance Transformative Therapies
OTR Therapeutics has secured USD 100 million in Series A funding to accelerate the development of its pipeline of differentiated therapies aimed at addressing major unmet needs across immunology, inflammation, oncology, and other disease areas.
Series A Funding | 05/12/2025 | By Dineshwori | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy